A. Krause

Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.

S. Hernández-Díaz, M. Dougados, P. Lipsky, 2000, The Journal of rheumatology.

T 1 Receptor Agonistic Antibodies , ypertension , and Preeclampsia

G. Wallukat, F. Luft, D. Müller, 2004 .

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still’s disease

Andreas Krause, G. Burmester, F. Buttgereit, 2010, Annals of the rheumatic diseases.

Efficacy, quality of life, and safety of methotrexate versus interferon in head-to-head treatment in advanced stages of mycosis fungoides and Sezary syndrome. Prospective trial (NCT02323659)

M. Sokołowska-Wojdyło, E. Chmielowska, K. Olek-Hrab, 2021, Postepy dermatologii i alergologii.

Safety and efficacy of interferon-alfa2b (IFN) in the treatment of patients with mycosis fungoides

K. Kalinowska, E. Chmielowska, A. Grzanka, 2011 .

Treatment of patients with primary cutaneous lymphomas – real-life data

M. Sokołowska-Wojdyło, E. Chmielowska, M. Studziński, 2019, Nowotwory. Journal of Oncology.

Follow-up of patients with mycosis fungoides after interferon α2b treatment failure

E. Chmielowska, A. Grzanka, S. Giebel, 2015, Postepy dermatologii i alergologii.

Combined salvage ibrutinib/rituximab therapy in chronic lymphocytic leukemia (del17p) with autoimmune cytopenias - case report

E. Chmielowska, A. Krause, Monika Olejniczakz, 2019, Hematology & Transfusion International Journal.